Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
about
Therapeutic Strategies in HCC: Radiation ModalitiesLiver resection and transplantation in hepatocellular carcinomaRecent advances in multidisciplinary management of hepatocellular carcinomaPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaA randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Hepatectomy for hepatocellular carcinoma in the era of liver transplantation.Systemic chemotherapy of liver tumors.Primary liver tumors.Gene expression in fixed tissues and outcome in hepatocellular carcinoma.Hepatocellular carcinoma--cause, treatment and metastasis.Hepatocellular carcinoma: is current therapy really altering outcome?Prognostic prediction and treatment strategy in hepatocellular carcinoma.The prognostic significance of clinical and pathological features in hepatocellular carcinoma.Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trialManagement of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.Hepatocellular carcinoma: current approaches to diagnosis and management.Radionuclide therapy of hepatocellular carcinoma.Surgery for hepatocellular carcinoma.Evidence-based medicine in the treatment of hepatocellular carcinoma.Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.Review article: intra-arterial treatments in patients with hepatocellular carcinoma.Hepatocellular carcinoma: are we making progress?Pharmacotherapy of hepatocellular carcinoma.Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.On the evolution of statistical methods as applied to clinical trials.Management of Hepatocellular Carcinoma: Current Status and Future Directions.Surgical management of hepatic malignancy.Systemic therapies for hepatocellular carcinoma.Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.Gene- and immunotherapy for hepatocellular carcinoma.Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.Hepatocellular carcinoma: therapy and prevention.Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.Adjuvant Intrahepatic Injection Iodine-131-Lipiodol Improves Prognosis of Patients with Hepatocellular Carcinoma After Resection: a Meta-Analysis.A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma.Surgical treatment of hepatocellular carcinoma: evidence-based outcomes
P2860
Q26738658-67210369-F4A4-49F8-AD6A-0A412576BA15Q26823395-1EBD9324-6755-4E48-8409-F4DF986B50C9Q26863748-671378A7-68CB-46E6-9004-6E6C564417D7Q28272678-F65454FF-F347-4080-B029-C10CF327FD19Q28392783-E3F69E05-7663-4E89-9920-610AE63467BEQ28394414-A3BD2559-3B2A-4269-A818-86C3F5641B0AQ33368982-A14DAC82-B867-4645-99FF-876BCC60D766Q33866448-24B2D0C8-844B-442D-AEF4-A96B97B860E4Q33948280-FCFF4039-4178-475C-AEF4-82E7D84ABC85Q34110952-8B536C77-B8E8-4A23-AB94-A0D3DBD2D981Q34110964-8698ED12-CF1F-4F9A-916D-150E5D4FA5DFQ34235518-B073CA51-6E78-4746-96E2-69E2EB252E0EQ34512068-2FADF0EB-828B-4948-AD75-C7BF2FA9BBF9Q34527230-49233311-DF04-48D4-BCAD-960A7A84C941Q34547469-88BB2496-04DD-4DBA-9448-5DC592FCA5B8Q34582844-02810858-90E7-4D90-A29B-C3F9C0996D7BQ34612069-72B71BCF-A6CF-46D1-AA6C-061EDFDFC759Q34681207-66C8E1F7-C4F6-404B-828A-20ADE1D1E305Q34773704-ABA285AB-9CC0-436E-8A3B-E2A4F4370767Q34991395-3114377A-5EB1-4D4D-85A3-C3606E04549BQ35020882-15E931E4-E731-40E8-AAEF-644694B44504Q35020890-617347CB-5764-4978-B240-8348473B1C66Q35101345-301B2C9B-FC48-4D16-8EDC-8F2271699AAFQ35145069-F1911FCD-8883-46D5-A495-EF526FE496A1Q35193283-26DFEFA0-5DFF-4485-894C-400A03786261Q35593957-9333B3F3-085B-459D-812E-C8E8AD3214ADQ35660038-FB0DDA52-0EDF-4A61-9148-8AE7F77867D7Q35743841-7CA556F0-282C-4DFB-BFA6-634EDEA3115BQ35771842-3FFFD5FE-CE2D-4FE9-9E0F-C133EFF1CB10Q35806757-6647A315-5F7E-42D8-98B2-70D4D23C6D16Q35964708-A0DFEB2C-638B-4767-A7B8-78077CCD8410Q36065568-3CA44C9E-8DEE-4E21-A95B-BCCB782C98E6Q36150432-022BA154-ACC4-4E98-9E4D-D1911B487394Q36301895-32088D2E-03A2-4920-93D3-7BB090B0F3ACQ36377949-80D29106-10B2-4867-844A-F45DF834BCF3Q36497118-D2AF42E4-8E0C-4ADC-A3CA-5A29E6766CA5Q36643622-5D9F8977-232F-4612-A33E-F43A133DE8D0Q36934253-774CD0A4-366F-43BC-A532-28338F863909Q37002609-245E8FD0-4269-403C-9AA1-EE0B423CB17CQ37060415-13EC9A8B-1226-4BC0-B449-EAE74FCCC641
P2860
Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Adjuvant intra-arterial iodine ...... prospective randomised trial.
@ast
Adjuvant intra-arterial iodine ...... prospective randomised trial.
@en
type
label
Adjuvant intra-arterial iodine ...... prospective randomised trial.
@ast
Adjuvant intra-arterial iodine ...... prospective randomised trial.
@en
prefLabel
Adjuvant intra-arterial iodine ...... prospective randomised trial.
@ast
Adjuvant intra-arterial iodine ...... prospective randomised trial.
@en
P2093
P1433
P1476
Adjuvant intra-arterial iodine ...... prospective randomised trial.
@en
P2093
P J Johnson
P304
P356
10.1016/S0140-6736(98)06475-7
P407
P577
1999-03-01T00:00:00Z